By Debdeep Gupta | 08 Sep, 2025
Aurobindo Pharma shares in focus on 8 observations from USFDA
Aurobindo Pharma share will remain in focus on September 8 following the company received eight observations from the United States Food and Drug Administration (USFDA).The USFDA inspected company's Unit-XII, including oral solids and injectable manufacturing unit, situated at Bachupally, Medchal Malkajgiri District, Telangana from August 25 to September 05, 2025.At the end of the current inspecti...
Live Comments